CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | Wasman Jane Director | Grant or award | +5,750 | 18,250 | ||
| 2025-05-23 | Wasman Jane Director | Grant or award | +2,500 | 12,500 | ||
| 2025-05-23 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2024-05-25 | Wasman Jane Director | Grant or award | +25,000 | 100,000 | ||
| 2024-05-25 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-26 | Wasman Jane Director | Grant or award | +25,000 | 75,000 | ||
| 2023-05-26 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 1 of 1 · 7 trades